The latest addition to Roche CustomBiotech's portfolio for the mRNA technology platform
Introducing our new GMP Grade, recombinant RNase inhibitor. Produced under stringent quality control, this enzyme is suitable for even highly regulated healthcare applications.
Compared to DNA, RNA degrades quickly in suboptimal conditions. The ubiquitous presence of RNases risks additional RNA loss. Protect RNA from enzymatic degradation with our high-performance RNase inhibitor, confident that it also meets fit-for-purpose criteria for mRNA drug development and manufacturing.